Home/Filings/4/0001209191-22-060702
4//SEC Filing

Vakharia Tejal 4

Accession 0001209191-22-060702

CIK 0001124804other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 4:30 PM ET

Size

5.6 KB

Accession

0001209191-22-060702

Insider Transaction Report

Form 4
Period: 2022-12-12
Vakharia Tejal
SVP General Counsel
Transactions
  • Sale

    Common Stock

    2022-12-12$18.42/sh8,642$159,193222,604 total
Footnotes (2)
  • [F1]The sale of shares reported in the Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2022.
  • [F2]These transactions were executed in multiple trades at prices ranging from $18.35 to $18.53. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected.

Issuer

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

CIK 0001124804

Entity typeother

Related Parties

1
  • filerCIK 0001815879

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:30 PM ET
Size
5.6 KB